OpenEvidence is rapidly consolidating its position as the primary AI operating system for American clinicians with the broad release of its AI-Integrated Doctor Dialer. This new feature moves beyond simple search, embedding sophisticated automated assistants directly into the messy reality of daily medical communication. By unifying calling, messaging, and faxing into a single interface, the platform addresses a critical pain point: the friction between maintaining patient privacy and ensuring high patient contact rates.

The tool's true power lies in its multistep architecture, which provides real-time clinical decision support while a doctor is still on the line. As the conversation unfolds, the system transcribes the interaction and suggests evidence-based recommendations, which are then automatically formatted into structured clinical notes. This seamless integration of "Visits"—the company's transcription engine—removes the administrative burden that traditionally follows patient interactions, effectively turning a simple phone call into a documented medical event.

The financial momentum behind OpenEvidence is equally staggering, with a recent $250 million Series D round doubling its valuation to $12 billion in just months. This capital infusion supports the massive compute costs required for their "medical super-intelligence" goal, which utilizes multimodal and multicloud systems to process diverse healthcare data. With nearly half of all U.S. doctors already on the platform, the company is no longer just a search tool but an essential central nervous system for modern healthcare delivery.

OpenEvidence is rapidly consolidating its position as the primary AI operating system for American clinicians with the broad release of its AI-Integrated Doctor Dialer. This new feature moves beyond simple search, embedding sophisticated automated assistants directly into the messy reality of daily medical communication. By unifying calling, messaging, and faxing into a single interface, the platform addresses a critical pain point: the friction between maintaining patient privacy and ensuring high patient contact rates.

The tool's true power lies in its multistep architecture, which provides real-time clinical decision support while a doctor is still on the line. As the conversation unfolds, the system transcribes the interaction and suggests evidence-based recommendations, which are then automatically formatted into structured clinical notes. This seamless integration of "Visits"—the company's transcription engine—removes the administrative burden that traditionally follows patient interactions, effectively turning a simple phone call into a documented medical event.

The financial momentum behind OpenEvidence is equally staggering, with a recent $250 million Series D round doubling its valuation to $12 billion in just months. This capital infusion supports the massive compute costs required for their "medical super-intelligence" goal, which utilizes multimodal and multicloud systems to process diverse healthcare data. With nearly half of all U.S. doctors already on the platform, the company is no longer just a search tool but an essential central nervous system for modern healthcare delivery.